Correlation Between Dogwood Therapeutics, and Vertex Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Dogwood Therapeutics, and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dogwood Therapeutics, and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dogwood Therapeutics, and Vertex Pharmaceuticals, you can compare the effects of market volatilities on Dogwood Therapeutics, and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dogwood Therapeutics, with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dogwood Therapeutics, and Vertex Pharmaceuticals.
Diversification Opportunities for Dogwood Therapeutics, and Vertex Pharmaceuticals
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Dogwood and Vertex is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Dogwood Therapeutics, and Vertex Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Dogwood Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dogwood Therapeutics, are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Dogwood Therapeutics, i.e., Dogwood Therapeutics, and Vertex Pharmaceuticals go up and down completely randomly.
Pair Corralation between Dogwood Therapeutics, and Vertex Pharmaceuticals
Given the investment horizon of 90 days Dogwood Therapeutics, is expected to under-perform the Vertex Pharmaceuticals. In addition to that, Dogwood Therapeutics, is 6.91 times more volatile than Vertex Pharmaceuticals. It trades about -0.03 of its total potential returns per unit of risk. Vertex Pharmaceuticals is currently generating about 0.05 per unit of volatility. If you would invest 40,465 in Vertex Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of 6,457 from holding Vertex Pharmaceuticals or generate 15.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dogwood Therapeutics, vs. Vertex Pharmaceuticals
Performance |
| Timeline |
| Dogwood Therapeutics, |
| Vertex Pharmaceuticals |
Dogwood Therapeutics, and Vertex Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dogwood Therapeutics, and Vertex Pharmaceuticals
The main advantage of trading using opposite Dogwood Therapeutics, and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dogwood Therapeutics, position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.| Dogwood Therapeutics, vs. Viking Therapeutics | Dogwood Therapeutics, vs. Vanda Pharmaceuticals | Dogwood Therapeutics, vs. Verrica Pharmaceuticals | Dogwood Therapeutics, vs. Viridian Therapeutics |
| Vertex Pharmaceuticals vs. Biomarin Pharmaceutical | Vertex Pharmaceuticals vs. Sarepta Therapeutics | Vertex Pharmaceuticals vs. Alnylam Pharmaceuticals | Vertex Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |